Success in clinical trial conduct is reliant upon several key aspects of control and quality throughout the entirety of the trial. Leveraging ICH E8 R1 recommendations for quality by design and proactive risk management, along with the addition of a customer-focused approach to foster relationships with collaborations can have a lasting impact and equip a trial for success and efficiency.
In this session, led by the WCG Avoca Quality Consortium we will connect, collaborate, and explore how quality relationships, planning, and adequate processes equate to greater success and sustainability in an environment where we are often doing more with less.
The Avoca Quality Consortium was founded on collaboration within the clinical trial environment to drive quality and efficiencies. This now realized mission connects 200+ stakeholder organizations in the effort to improve future clinical trials.
Linda Sullivan - Senior Advisor, Metrics & Performance Management - WCG
- Describe elements of ICH E8 R1 and WCG Avoca Quality Consortium inspection framework that facilitate inspection preparedness
- Explain and practice importance of communication, building relationships, and collaboration among clinical trial stakeholders
- Identify the role of purpose driven quality planning and risk management in overall trial success